Nonalcoholic fatty liver disease and hepatocellular carcinoma.
about
Schisandrin B: A Double-Edged Sword in Nonalcoholic Fatty Liver DiseaseImmune surveillance of liver cancer in non-alcoholic fatty liver disease: excess lipids cause CD4 T-cells loss and promote hepatocellular carcinoma developmentActivated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma CellsPeritumoral Hyperplasia in Hepatic Sclerosed Hemangioma.Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study.Predicting organ toxicity using in vitro bioactivity data and chemical structure.PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.Activin A and follistatin in patients with nonalcoholic fatty liver disease.Peretinoin as an adjuvant therapy for hepatocellular carcinoma.Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis.Getting the Skinny on CD4(+) T Cell Survival in Fatty Livers.Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease.Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions.Collagen I promotes hepatocellular carcinoma cell proliferation by regulating integrin β1/FAK signaling pathway in nonalcoholic fatty liver.A disease-specific quality of life instrument for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: CLDQ-NAFLD.Proceedings of the 2017 ASPEN Research Workshop-Gastric Bypass: Role of the Gut.Impact of Individual Components of the Metabolic Syndrome on the Outcome of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus.Gut microbiome and liver diseases.Decrease of Pericytes is Associated With Liver Disease Caused by Ligature-Induced Periodontitis in Rats.Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B.Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.Nonalcoholic fatty liver disease and hepatocellular carcinomaGlycyrrhizin Alleviates Nonalcoholic Steatohepatitis via Modulating Bile Acids and Meta-Inflammation
P2860
Q28078342-2C58F5C2-8425-4C2B-9C5D-0AEA09414C73Q28392282-DCC3713E-D762-469A-8111-46B412C6B70CQ28555059-B664A7BD-A81C-4165-96C2-1A612AF62E44Q33609830-A38C9059-693F-4331-85A8-E5A2A7F883C2Q37685731-4734F99D-3556-4C08-9F22-5DA2BD9999B4Q38646520-E4E6FFE5-D037-4CCD-AC27-57B803440FE2Q38674742-FFFDD965-457F-43E1-8168-4AED3767050AQ38821923-37D4802F-ACBD-48ED-A0E9-FAE7383DB95DQ38959682-E675CFC2-179B-41CB-B5FE-6CECB56E97A4Q38961355-B31EA99B-8993-47C1-89E5-90541443A9D8Q39177080-B2DB747E-CF42-4825-9D86-540735AC845AQ40706956-EA8E61DD-ED93-43EC-9A53-7E718536E38DQ41050215-BA3E88B9-851B-4B20-9279-5000A042BDA6Q41573222-DAF190CD-9FE2-4E50-BA24-3FCB6FFBA199Q47113983-B5349A3F-7F6D-4B68-8809-9D27DC702156Q47966842-3B5C01FB-E84E-4D42-A941-6BE01EEF3674Q50005567-88D76AA8-F3CF-45A3-B17B-DD9824320654Q51833803-971534D6-B1A9-4149-B969-D8D119CB4133Q52624083-8073907F-B657-46BB-AB29-69EB35101A80Q52839364-1005CF99-F457-47CE-843E-8921C9226F8AQ52847312-5128725B-D87D-4FEA-B881-016543ECAEE4Q55258217-4055D466-631D-4ADC-80EF-8C19C95CD4F5Q55379918-1A12F344-6A75-49D2-8C8A-ACBE8BB20D9AQ57095486-B577783E-E348-4EDD-85DE-4436728D1E34Q57109511-6895269D-12A6-4BA7-81A5-1B3E947B8083
P2860
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@ast
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@en
type
label
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@ast
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@en
prefLabel
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@ast
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@en
P1433
P1476
Nonalcoholic fatty liver disease and hepatocellular carcinoma.
@en
P2093
Heinz Zoller
Herbert Tilg
P304
P356
10.1016/J.METABOL.2016.01.010
P577
2016-01-23T00:00:00Z